迪戈辛的最佳剂量是什么?

Dementia, osteoporosis and fragility fractures: Intricate epidemiological relationships, plausible biological connections, and twisted clinical practices.

Ageing research reviews·2023

Patients' needs in proton therapy: A survey among ten European facilities.

Clinical and translational radiation oncology·2023

Prehabilitation and heart failure: perspective in primary outcomes, a randomized controlled trial.

European review for medical and pharmacological sciences·2021

Polypharmacy is a determinant of hospitalization in Parkinson's disease.

European review for medical and pharmacological sciences·2021

Effects of aging and life-long moderate calorie restriction on IL-15 signaling in the rat white adipose tissue.

European review for medical and pharmacological sciences·2020

25(OH) vitamin D and functional outcomes in older adults admitted to rehabilitation units: the safari study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Signal logic gate mediated by a controllable CRISPR/Cas12a system for simultaneous detection of DNA mutation and methylation.

Analytical methods : advancing methods and applications·2026

AAPM/EFOMP TG282 versus dance dosimetry for digital breast tomosynthesis in the assessment pathway of a breast screening program.

Medical physics·2026

Repurposing CRISPR-associated transposases for engineering microbiology.

Trends in biotechnology·2026

Controllable synthesis of dermoscopic images using diffusion models for enhanced computer aided diagnosis and detection.

Medical image analysis·2026

Digital health technologies for the management of sarcopenia in patients receiving maintenance hemodialysis: a narrative review.

Frontiers in nutrition·2026

The moderating role of personality in the associations between delay discounting and technology use among older adults.

The journals of gerontology. Series B, Psychological sciences and social sciences·2026

相关实验视频

迪戈辛的最佳剂量是什么?

相关概念视频

Dementia, osteoporosis and fragility fractures: Intricate epidemiological relationships, plausible biological connections, and twisted clinical practices.

Patients' needs in proton therapy: A survey among ten European facilities.

Prehabilitation and heart failure: perspective in primary outcomes, a randomized controlled trial.

Polypharmacy is a determinant of hospitalization in Parkinson's disease.

Effects of aging and life-long moderate calorie restriction on IL-15 signaling in the rat white adipose tissue.

25(OH) vitamin D and functional outcomes in older adults admitted to rehabilitation units: the safari study.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Signal logic gate mediated by a controllable CRISPR/Cas12a system for simultaneous detection of DNA mutation and methylation.

AAPM/EFOMP TG282 versus dance dosimetry for digital breast tomosynthesis in the assessment pathway of a breast screening program.

Repurposing CRISPR-associated transposases for engineering microbiology.

Controllable synthesis of dermoscopic images using diffusion models for enhanced computer aided diagnosis and detection.

Digital health technologies for the management of sarcopenia in patients receiving maintenance hemodialysis: a narrative review.

The moderating role of personality in the associations between delay discounting and technology use among older adults.

相关实验视频

迪戈辛的最佳剂量是什么?

相关概念视频

相关文章